Across rural Africa, a quiet revolution is taking place, one that’s saving lives and strengthening communities.
This short video tells a powerful story of how autologous blood transfusion is transforming maternal healthcare in low-resource settings. In areas where donor blood is scarce, HemoClear’s autologous bloodtransfusion is bridging critical gaps with a low-tech, high-impact solution.
Lorem ipsum etc…
Sub-Saharan African countries continue to struggle with chronic, year-round blood shortages, limiting their ability to support patients and deliver on the health-related Sustainable Development Goals (SDGs).
Important research quantifies the global scarcity of life-saving donor blood. As a result an estimated 10 million patients unnecessarily suffer or die annually . This is caused by a 30 …
Hemoclear joins forces with VDL HemoClear joins forces with VDL in manufacturing the HemoClear autologous blood filter. The Dutch innovation HemoClear is the first blood filter that allows patients shed …
Last week at the Medica in Dusseldorf, HemoClear and Medista signed an distribution agreement. In this agreement we assign the exclusive commercial distribution rights for the Czech Republic to Medista. …
In the strategic ambition to optimize production, increase flexibility, and decrease lead times and costs, HemoClear will centralize all production activities in the Netherlands. As a promising kick-off of …
We just received the results of a HemoClear study performed by EFS. The report confirms that over 99.9% of red blood cells remain well-preserved during, and up to seven days …
As a proud sponsor, HemoClear attended the Bloodless Medicine and Surgery Society Annual Meeting. At the event Dr Rosita Bihariesingh presented a case of severe bleeding after surgery, HemoClear provided …
